FORMAN ERIC 13D/13G Filings for Lixte Biotechnology Holdings, Inc. (LIXT)

FORMAN ERIC 13D and 13G filings for Lixte Biotechnology Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-04-06
9:59 pm
Sale
2021-12-1713GLixte Biotechnology Holdings, Inc.
LIXT
FORMAN ERIC11,043
0.075%
-130,615decrease
(-92.20%)
Filing